Literature DB >> 24845512

The evolutionary strata of DARPP-32 tail implicates hierarchical functional expansion in higher vertebrates.

Choong Yong Ung1, Teow Chong Teoh.   

Abstract

DARPP-32 (dopamine and adenosine 3', 5'-monophosphate-regulated phosphoprotein of 32 kDa), which belongs to PPP1R1 gene family, is known to act as an important integrator in dopamine-mediated neurotransmission via the inhibition of protein phosphatase-1 (PP1). Besides its neuronal roles, this protein also behaves as a key player in pathological and pharmacological aspects. Use of bioinformatics and phylogenetics approaches to further characterize the molecular features of DARPP-32 can guide future works. Predicted phosphorylation sites on DARPP-32 show conservation across vertebrates. Phylogenetics analysis indicates evolutionary strata of phosphorylation site acquisition at the C-terminus, suggesting functional expansion of DARPP-32, where more diverse signalling cues may involve in regulating DARPP-32 in inhibiting PP1 activity. Moreover, both phylogenetics and synteny analyses suggest de novo origination of PPP1R1 gene family via chromosomal rearrangement and exonization.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24845512     DOI: 10.1007/s12038-014-9438-8

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  41 in total

1.  Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.

Authors:  Elmar Krieger; Günther Koraimann; Gert Vriend
Journal:  Proteins       Date:  2002-05-15

2.  GPS: a novel group-based phosphorylation predicting and scoring method.

Authors:  Feng-Feng Zhou; Yu Xue; Guo-Liang Chen; Xuebiao Yao
Journal:  Biochem Biophys Res Commun       Date:  2004-12-24       Impact factor: 3.575

3.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.

Authors:  B Meister; J Fryckstedt; M Schalling; R Cortés; T Hökfelt; A Aperia; H C Hemmings; A C Nairn; M Ehrlich; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1.

Authors:  J Goldberg; H B Huang; Y G Kwon; P Greengard; A C Nairn; J Kuriyan
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

5.  A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions.

Authors:  S I Walaas; D W Aswad; P Greengard
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

6.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus.

Authors:  H C Hemmings; A C Nairn; D W Aswad; P Greengard
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

7.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.

Authors:  J A Bibb; G L Snyder; A Nishi; Z Yan; L Meijer; A A Fienberg; L H Tsai; Y T Kwon; J A Girault; A J Czernik; R L Huganir; H C Hemmings; A C Nairn; P Greengard
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Structural diversity in free and bound states of intrinsically disordered protein phosphatase 1 regulators.

Authors:  Joseph A Marsh; Barbara Dancheck; Michael J Ragusa; Marc Allaire; Julie D Forman-Kay; Wolfgang Peti
Journal:  Structure       Date:  2010-09-08       Impact factor: 5.006

9.  t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer.

Authors:  Bhavatarini Vangamudi; Dun-Fa Peng; Qiuyin Cai; Wael El-Rifai; Wei Zheng; Abbes Belkhiri
Journal:  Mol Cancer       Date:  2010-09-13       Impact factor: 27.401

10.  GPS: a comprehensive www server for phosphorylation sites prediction.

Authors:  Yu Xue; Fengfeng Zhou; Minjie Zhu; Kashif Ahmed; Guoliang Chen; Xuebiao Yao
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.